Mechanism of 5-azacytidine-induced transfer rna cytosine-5-methyltransferase deficiency

Leejane Lu, Kurt Randerath

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The administration of 5-azacytidine to mice leads to a specific, rapid, time-dependent, and dose-dependent decrease of transfer RNA (tRNA) cytosine-5-methyltransferase activity of mouse liver and the synthesis of tRNA specifically lacking 5-methylcytidine. The mechanism of this enzyme deficiency was investigated. The pretreatment of mice with RNA synthesis inhibitors such as actinomycin D and D-galactosamine prevented the enzyme deficiency induced by 5-azacytidine administration. These results suggested that RNA synthesis was a prerequisite for the induction by 5-azacytidine of the enzyme inhibition in vivo. Indeed, a slowly sedimenting RNA (4 to 7S) from the livers of mice treated with 5-azacytidine, when present in an in vitro tRNA methyltransferase assay, decreased specifically the activity of tRNA cytosine-5-methyltransferase. The pretreatment of mice with actinomycin D or D-galactosamine prior to the administration of 5-azacytidine effectively prevented the formation of such inhibitory RNA in vivo as determined by an in vitro tRNA methyltransferase assay. These results indicate that the administration of 5-azacytidine to mice leads to the rapid synthesis of a low-molecular-weight RNA fraction which is capable of specifically inactivating tRNA cy-tosine-5-methyltransferase activity in vivo and in vitro.

Original languageEnglish (US)
Pages (from-to)2701-2705
Number of pages5
JournalCancer Research
Volume40
StatePublished - Aug 1 1980
Externally publishedYes

Fingerprint

Azacitidine
Transfer RNA
tRNA Methyltransferases
RNA
Galactosamine
Dactinomycin
Enzymes
Nucleic Acid Synthesis Inhibitors
Liver
Methyltransferases
Cytosine 5-methyltransferase
Molecular Weight
In Vitro Techniques

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mechanism of 5-azacytidine-induced transfer rna cytosine-5-methyltransferase deficiency. / Lu, Leejane; Randerath, Kurt.

In: Cancer Research, Vol. 40, 01.08.1980, p. 2701-2705.

Research output: Contribution to journalArticle

@article{b72257ced35f43ac904ad317ede8d990,
title = "Mechanism of 5-azacytidine-induced transfer rna cytosine-5-methyltransferase deficiency",
abstract = "The administration of 5-azacytidine to mice leads to a specific, rapid, time-dependent, and dose-dependent decrease of transfer RNA (tRNA) cytosine-5-methyltransferase activity of mouse liver and the synthesis of tRNA specifically lacking 5-methylcytidine. The mechanism of this enzyme deficiency was investigated. The pretreatment of mice with RNA synthesis inhibitors such as actinomycin D and D-galactosamine prevented the enzyme deficiency induced by 5-azacytidine administration. These results suggested that RNA synthesis was a prerequisite for the induction by 5-azacytidine of the enzyme inhibition in vivo. Indeed, a slowly sedimenting RNA (4 to 7S) from the livers of mice treated with 5-azacytidine, when present in an in vitro tRNA methyltransferase assay, decreased specifically the activity of tRNA cytosine-5-methyltransferase. The pretreatment of mice with actinomycin D or D-galactosamine prior to the administration of 5-azacytidine effectively prevented the formation of such inhibitory RNA in vivo as determined by an in vitro tRNA methyltransferase assay. These results indicate that the administration of 5-azacytidine to mice leads to the rapid synthesis of a low-molecular-weight RNA fraction which is capable of specifically inactivating tRNA cy-tosine-5-methyltransferase activity in vivo and in vitro.",
author = "Leejane Lu and Kurt Randerath",
year = "1980",
month = "8",
day = "1",
language = "English (US)",
volume = "40",
pages = "2701--2705",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Mechanism of 5-azacytidine-induced transfer rna cytosine-5-methyltransferase deficiency

AU - Lu, Leejane

AU - Randerath, Kurt

PY - 1980/8/1

Y1 - 1980/8/1

N2 - The administration of 5-azacytidine to mice leads to a specific, rapid, time-dependent, and dose-dependent decrease of transfer RNA (tRNA) cytosine-5-methyltransferase activity of mouse liver and the synthesis of tRNA specifically lacking 5-methylcytidine. The mechanism of this enzyme deficiency was investigated. The pretreatment of mice with RNA synthesis inhibitors such as actinomycin D and D-galactosamine prevented the enzyme deficiency induced by 5-azacytidine administration. These results suggested that RNA synthesis was a prerequisite for the induction by 5-azacytidine of the enzyme inhibition in vivo. Indeed, a slowly sedimenting RNA (4 to 7S) from the livers of mice treated with 5-azacytidine, when present in an in vitro tRNA methyltransferase assay, decreased specifically the activity of tRNA cytosine-5-methyltransferase. The pretreatment of mice with actinomycin D or D-galactosamine prior to the administration of 5-azacytidine effectively prevented the formation of such inhibitory RNA in vivo as determined by an in vitro tRNA methyltransferase assay. These results indicate that the administration of 5-azacytidine to mice leads to the rapid synthesis of a low-molecular-weight RNA fraction which is capable of specifically inactivating tRNA cy-tosine-5-methyltransferase activity in vivo and in vitro.

AB - The administration of 5-azacytidine to mice leads to a specific, rapid, time-dependent, and dose-dependent decrease of transfer RNA (tRNA) cytosine-5-methyltransferase activity of mouse liver and the synthesis of tRNA specifically lacking 5-methylcytidine. The mechanism of this enzyme deficiency was investigated. The pretreatment of mice with RNA synthesis inhibitors such as actinomycin D and D-galactosamine prevented the enzyme deficiency induced by 5-azacytidine administration. These results suggested that RNA synthesis was a prerequisite for the induction by 5-azacytidine of the enzyme inhibition in vivo. Indeed, a slowly sedimenting RNA (4 to 7S) from the livers of mice treated with 5-azacytidine, when present in an in vitro tRNA methyltransferase assay, decreased specifically the activity of tRNA cytosine-5-methyltransferase. The pretreatment of mice with actinomycin D or D-galactosamine prior to the administration of 5-azacytidine effectively prevented the formation of such inhibitory RNA in vivo as determined by an in vitro tRNA methyltransferase assay. These results indicate that the administration of 5-azacytidine to mice leads to the rapid synthesis of a low-molecular-weight RNA fraction which is capable of specifically inactivating tRNA cy-tosine-5-methyltransferase activity in vivo and in vitro.

UR - http://www.scopus.com/inward/record.url?scp=84969102960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969102960&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 2701

EP - 2705

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

ER -